Details for New Drug Application (NDA): 202379
✉ Email this page to a colleague
The generic ingredient in ZYTIGA is abiraterone acetate. There are twenty-five drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the abiraterone acetate profile page.
Summary for 202379
Tradename: | ZYTIGA |
Applicant: | Janssen Biotech |
Ingredient: | abiraterone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 202379
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYTIGA | abiraterone acetate | TABLET;ORAL | 202379 | NDA | Janssen Biotech, Inc. | 57894-150 | 57894-150-12 | 120 TABLET in 1 BOTTLE (57894-150-12) |
ZYTIGA | abiraterone acetate | TABLET;ORAL | 202379 | NDA | Janssen Biotech, Inc. | 57894-195 | 57894-195-06 | 60 TABLET, FILM COATED in 1 BOTTLE (57894-195-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
Approval Date: | Apr 28, 2011 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Apr 14, 2017 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 202379
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Biotech | ZYTIGA | abiraterone acetate | TABLET;ORAL | 202379-001 | Apr 28, 2011 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription